Alkem Labs faces a setback with the US FDA’s ten observations for the Himachal unit1
US FDA issued 10 observations for Alkem Laboratories’ Baddi plant. No data integrity issues noted during the inspection. Shares fell 3% following the news. Previous allegations of tax evasion denied by the company. Despite challenges, stock gained 40% in the past six months. Alkem Laboratories’ shares fell 3% in early trade on March 28, following … Read more